Collaborators‎ > ‎

Michael Chung, MD, MPH, Associate Professor


Dr. Chung received his medical degree from the University of Chicago Pritzker School of Medicine and a Master’s in Public Health degree from the Harvard School of Public Health.  He trained in Internal Medicine at the Beth Israel Deaconess Medical Center and Infectious Diseases at the University of Washington, and is board certified in both specialties.


Dr. Chung has been living and working in Nairobi, Kenya and Hanoi, Vietnam since 2002. At these sites in Africa and Southeast Asia, he has been involved in HIV treatment and care, field epidemiology research, and medical education. He has led several randomized controlled trials on a variety of topic including perinatal transmission of HIV, adherence to antiretroviral medications, and treatment of cervical intraepithelial neoplasia among HIV-positive women. In 2004, Dr. Chung co-founded the Coptic Hope Center for Infectious Diseases, an HIV clinic in Nairobi which is one of the largest single-site antiretroviral treatment centers in Africa. He is the Director of the Treatment, Research, and Expert Education (TREE) program which is dedicated to addressing the health needs of people living in resource-limited settings through quality medical care, academic research, training and education. Dr. Chung's current interests include cervical cancer screening and treatment of HIV-positive women, education of health care workers in resource-limited settings through the internet, and HIV treatment of injection drug users in Vietnam.


Representative Publications 

 McGrath CJ, Chung MH, Richardson B, Benki-Nugent S, John-Stewart G.  Younger age at HAART initiation is associated with more rapid growth reconstitution.  AIDS. In press.


Pyne-Mercier LD, John-Stewart GC, Richardson BA, Kagondu NL, Thiga J, Noshy H, Kist N, Chung MH. The Consequences of Post-Election Violence on Antiretroviral HIV Therapy in Kenya. AIDS Care. In Press.


Chung MH, Kohler P, Attwa M, Thiga J, John-Stewart, GC. Comparing Clinic Retention between Residents and Non-residents of Kibera, Kenya. J Acquir Immune Defic Syndr 2010, Mar 1;53(3):422-4. [abstract] 


Lehman DA, Chung MH, Mabuka JM, John-Stewart GC, Kiarie J, Kinuthia J, Overbaugh J. Lower risk of resistance following short-course HAART compared to zidovudine/single-dose nevirapine used for prevention of HIV-1 mother-to-child transmission. J Acquir Immune Defic Syndr 2009, Aug 15;51(5):522-9. PMCID: PMC2765911 [Available on August 14, 2010] [abstract] 


Chung MH, Drake AL, Richardson BA, Reddy A, Thiga J, Sakr SR, Kiarie JN, Yowakim P, John-Stewart GC. Impact of Prior HAART Use on Clinical Outcomes in a Large Kenyan HIV Treatment Program. Current HIV Research 2009, Jul;7(4):441-6. PMCID: PMC2735680 [Available on July 1, 2010] [abstract] 


Chung MH, Kiarie J, Richardson B, Lehman D, Overbaugh J, Kinuthia J, Njiri F, John-Stewart G. Highly Active Antiretroviral Therapy (HAART) versus Zidovudine/Nevirapine Effects on Breastmilk HIV-1 RNA: A Phase II Randomized Clinical Trial. Antiviral Therapy 2008, 13(6):799-807. PMCID: PMC2859833 [abstract] 


Lehman D, Chung MH, John-Stewart G, Richardson B, Kiarie J, Overbaugh J. HIV-1 Persists in Breast Milk Cells Despite ART to Prevent Mother-to-Child Transmission. AIDS 2008, Jul 31;22(12):1475-85.  PMCID: PMC2765916 [abstract] 


Chung MH, Kiarie J, Richardson B, Lehman D, Njiri F, Overbaugh J, John-Stewart G. Independent Effects of Nevirapine Prophylaxis and HIV-1 RNA Suppression in Breast Milk on Early Perinatal HIV-1 Transmission J Acquir Immune Defic Syndr 2007, Dec 1;46(4):472-8. [abstract] 


Chung MH, Kiarie J, Richardson B, Lehman D, Overbaugh J, John-Stewart G. Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine vs. short-course zidovudine. AIDS 2005, Sep 2;19(13):1415-22. [abstract]